Core Viewpoint - UBS reports that the National Financial Regulatory Administration has issued guidelines to promote the high-quality development of health insurance, which is seen as positive and significant [1] Group 1: Regulatory Changes - The guidelines allow insurance companies with good regulatory ratings to launch participating dividend-type long-term health insurance products [1] - Implementation details are not finalized, but a transitional solution is expected to involve a combination of dividend savings policies and critical illness riders [1] - Despite the introduction of dividend features, regulators will continue to focus on the fundamental purpose of protection [1] Group 2: Market Comparison - The introduction of dividend-type critical illness insurance in mainland China is expected to have limited competitive impact on the Hong Kong market for insurance sales to mainland visitors [1] - Hong Kong's dividend products typically offer higher demonstration rates, around 6%-6.5%, compared to mainland rates of 2.9%-3.3% [1] - Hong Kong insurance products provide a broader range of global investment options, catering to the asset diversification needs of visitors [1] Group 3: Key Success Factors - Key success factors for dividend health insurance include strong regulatory ratings, investment and distribution capabilities, a focus on protection products, and the development of a medical ecosystem [1] - Friends Health China is viewed as a major beneficiary of these developments [1] - Among domestic listed insurance companies, China Ping An (02318) is relatively focused on protection products and has a well-established online and offline medical ecosystem, which may create synergies with health products like critical illness insurance [1]